Trial Details

TERMINATED
Basic Information
Clinical ID c1222
Identifier NCT02000453
Trial Title Safety and Tolerability Study of GSK2586184 in Patients With Moderate to Severely Active Ulcerative Colitis.
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Colitis, Ulcerative
Interventions DRUG: GSK2586184 400mg
Participant Information
Sponsor GlaxoSmithKline
City Amsterdam
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2013-12-20
Primary Completion Date 2014-08-08
Completion Date 2014-08-08